Browsing: files

Thanks for tuning in to this podcast from Teacher Magazine, the re for Educational Research. I’m Dominique Beech. 

|| A view of JW Pharmaceutical’s headquarters. Photo courtesy of JW Pharmaceutical

The pharmaceutical company Eli Lilly is studying a new obesity drug called retatrutide. The drug has not yet been approved by the Food and Drug Administration, but that hasn’t stopped people from selling unapproved versions

The fitness studio sector has faced economic issues over the last year with operators closing gym locations and, in some cases, filing for bankruptcy

JPS Health Network has filed a “catastrophe notice” with the Texas Attorney General as the health system works through a network disruption

On July 27, REX Shares filed for the REX Peptides ETF tracking the VettaFi Peptides Index. The fund targets companies strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products. Peptides, short chains of amino acids linked together in a specific sequence, appear in a range of products including medicines, dietary supplements,…

Thanks for tuning in to this podcast from Teacher Magazine, the re for Educational Research. I’m Dominique Beech. 

Hello and thanks for tuning in to this podcast from Teachermagazine, the re for Educational Research. I’m Jo Earp

Metabolic health-focused drug developer Kalohexis is eyeing a debut on the public market after confidentially filing for an initial public offering (IPO) – potentially adding it to a growing list of American biotechs that have opted to go public thus far in 2026

Ascletis files two FDA INDs for once-monthly obesity drugs targeting amylin, GLP-1R, and GIPR